Bimal R. Shah - 06 Oct 2023 Form 3 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Director
Signature
/s/ Bimal Shah
Issuer symbol
ANEB
Transactions as of
06 Oct 2023
Net transactions value
$0
Form type
3
Filing time
10 Oct 2023, 21:46:29 UTC
Next filing
17 Jun 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.